We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.4B
AUM Growth
+$501M
Cap. Flow
-$544M
Cap. Flow %
-4.05%
Top 10 Hldgs %
33.24%
Holding
1,308
New
44
Increased
620
Reduced
282
Closed
30

Top Sells

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$187M
2
WPC icon
W.P. Carey
WPC
+$162M
3
WELL icon
Welltower
WELL
+$126M
4
OHI icon
Omega Healthcare
OHI
+$110M
5
PLD icon
Prologis
PLD
+$84.3M

Sector Composition

Rank Sector Weight
1 Real Estate 60.72%
2 Technology 6.71%
3 Communication Services 3.62%
4 Consumer Discretionary 3.29%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNKD icon
1126
MannKind Corp
MNKD
$1.21B
$2K ﹤0.01%
437
MRSN
1127
DELISTED
Mersana Therapeutics
MRSN
$2K ﹤0.01%
5
NKTX icon
1128
Nkarta
NKTX
$159M
$2K ﹤0.01%
61
NRIX icon
1129
Nurix Therapeutics
NRIX
$2.51B
$2K ﹤0.01%
73
OCUL icon
1130
Ocular Therapeutix
OCUL
$1.85B
$2K ﹤0.01%
134
OMER icon
1131
Omeros
OMER
$816M
$2K ﹤0.01%
116
ORIC icon
1132
Oric Pharmaceuticals
ORIC
$1.23B
$2K ﹤0.01%
69
PASG icon
1133
Passage Bio
PASG
$14.7M
$2K ﹤0.01%
4
PCVX icon
1134
Vaxcyte
PCVX
$7.88B
$2K ﹤0.01%
96
PRTA icon
1135
Prothena Corp
PRTA
$448M
$2K ﹤0.01%
88
PSNL icon
1136
Personalis
PSNL
$1.27B
$2K ﹤0.01%
73
PTGX icon
1137
Protagonist Therapeutics
PTGX
$8.8B
$2K ﹤0.01%
81
QNCX icon
1138
Quince Therapeutics
QNCX
$18.9M
0
RNAM
1139
DELISTED
Avidity Biosciences
RNAM
$2K ﹤0.01%
71
RPTX
1140
DELISTED
Repare Therapeutics
RPTX
$2K ﹤0.01%
69
RYTM icon
1141
Rhythm Pharmaceuticals
RYTM
$7.41B
$2K ﹤0.01%
98
+15
+18% +$435
SNDX icon
1142
Syndax Pharmaceuticals
SNDX
$1.74B
$2K ﹤0.01%
93
+16
+21% +$361
STRO icon
1143
Sutro Biopharma
STRO
$393M
$2K ﹤0.01%
9
+2
+29% +$475
TBPH icon
1144
Theravance Biopharma
TBPH
$875M
$2K ﹤0.01%
120
VNDA icon
1145
Vanda Pharmaceuticals
VNDA
$310M
$2K ﹤0.01%
120
YMAB
1146
DELISTED
Y-mAbs Therapeutics
YMAB
$2K ﹤0.01%
76
TVRD
1147
Tvardi Therapeutics
TVRD
$22.9M
$2K ﹤0.01%
3
PETQ
1148
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
55
GTHX
1149
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2K ﹤0.01%
72
AERI
1150
DELISTED
Aerie Pharmaceuticals
AERI
$2K ﹤0.01%
102

Similar funds

Daiwa Securities Group's Q1 2021 Portfolio in Review

As of Q1 2021, Daiwa Securities Group held 1,308 positions worth $13.4B, up 3.9% from $12.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $544M in Q1 2021, closing 30 positions and reducing 282 holdings. Its most notable exit was Global X Aging Population ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 61% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Daiwa Securities Group opened a new position in Global X Social Media ETF worth $73.4M.

  • Daiwa Securities Group's largest Q1 2021 buy was Global X Social Media ETF: 1,100,000 shares worth $73.4M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q1 2021, an estimated $154M increase.
  • Daiwa Securities Group's biggest Q1 2021 reduction was Simon Property Group, cutting an estimated $187M.
  • Daiwa Securities Group fully exited Global X Aging Population ETF in Q1 2021, selling an estimated $13.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
  • Daiwa Securities Group opened 44 new positions and closed 30 in Q1 2021.
  • Daiwa Securities Group's portfolio value rose 3.9% quarter-over-quarter to $13.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2021, filed 3 May 2021.